Color’s software is increasing access to COVID-19 testing across California
With simplified site setup, easy sample collection, and seamless results reporting, our integrated software is serving residents across California. Our collaboration with PerkinElmer and the State of California is powering 150,000 new tests a day.
Learn More
A data-driven platform for population health
From population genomics programs to high-throughput COVID-19 testing, Color provides the technology and infrastructure for large-scale health initiatives.
Color’s COVID-19 Response
Color expands partnership with the National Institutes of Health
NIH awards $4.6 million to Color to provide genetic counseling and technological infrastructure for the million-person All of Us Research Program.
Read the press release
Designed for people. Built for populations.
Population Genomics Platform
We provide the technology and services to power successful population genomics programs. Our platform can be deployed as a complete, end-to-end solution or used modularly to support existing capabilities.
COVID-19
Testing Initiative
Our COVID-19 testing platform includes integrated software for health agencies to manage risk screening, test ordering, results delivery, case management, and case reporting.
Color for
Providers
Learn how you can send Color’s saliva test kits to your patients’ homes or order testing in your clinic. Get actionable results and access to our board-certified genetic counselors.
Revolutionizing healthcare delivery and research with leaders in population genomics
From the National Institutes of Health’s All of Us Research Program, to premier health systems, and partnerships with leading employers around the world.
For Health Systems
Bring innovation to patient care delivery.
Organic engagement with clinical value
Attract new patients in a competitive market with easy access to clinical-grade genetic information.
Unique insights for your population
Manage patient health at the individual and population levels with ongoing data collection.
Personalized routing to care pathways
Drive desired behavior with digital onboarding and routing to the right care pathways for each patient.
Increased capacity at lower cost
Transform your cost structures with digital tools to make virtual and in-person clinical services more efficient.
Learn MoreSpotlight on Research
Return genetic results to your population at scale.
NIH / All of Us
All of Us is sequencing one million people to accelerate health research and enable individualized prevention, treatment, and care.
UCSF / WISDOM
WISDOM is providing genetic testing for 100,000 women to make breast cancer screening more effective.
SU2C / MAGENTA
MAGENTA provides genetic testing and tele-counseling to women at high risk of cancer.
UW / GENtleMEN
GENtleMEN provides genetic testing and counseling to men with metastatic prostate cancer.
For Employers
Transform your employees’ engagement in their health decisions.
Personal context for healthcare decisions
Activate employees with clinical-grade genetics, personal and family health history, and other insights.
Increased participation and engagement
Get employees to be more proactive about their health with personalized routing to relevant screening guidelines and benefits programs.
Better control over costly health events
Mitigate costly health events by helping high-risk populations earlier.
Insights to help inform benefits planning
Receive custom reports with ongoing aggregated insights into your population’s health.
Learn MoreThe Latest from Color
To Get Back to Work, Companies Seek Coronavirus Tests for Workers
“The core tool we have to work with right now is direct covid testing,” said Othman Laraki, CEO of genetic-testing company Color, which is currently managing a testing site for San Francisco first responders as well as other essential city employees.
COVID-19 testing to keep employees safe
CNBC highlights how Color’s “digitally streamlined” COVID-19 testing program is helping Verve Therapeutics and a large group of biotechnology companies keep their employees as safe as possible.
Color announces $75 million funding round
Fortune Exclusive details $75 million funding round led by T. Rowe Funds and Viking Global Investors.
Let’s Get Started
If you’d like to chat about Color in more detail, complete this form and we’ll get back to you.
In the meantime, here are some other helpful links: Offer Color to Your Patients or Get a Color Test for Yourself
IF YOU HAVE ANY PROBLEMS VIEWING THE FORM FIELDS BELOW:
- Please make sure to click on the link to “Accept All Cookies”.
- Refresh your web page.